Top Stories
A picture inside an empty theatre in Netflix's Tokyo office with Netflix logo on the screen

Netflix Stock Price Soars After Earnings Report Record New Memberships

Netflix stock price ( NASDAQ: NFLX ) is up more than 13% in the after-hours following its release of the fourth-quarter earnings report for fiscal year 2024. The streaming company recorded a 16% increase in revenue year-over-year, reaching 19% on a foreign exchange (F/X) neutral basis, which the

A smartphone on a surface showing Chipotle ad on screen

If you invested $1000 in Chipotle Mexican Grill (NYSE:CMG) 5 years ago, here's how much it's worth today

They say, “If it looks like a restaurant, cooks food like a restaurant, and serves food like a restaurant, then it’s probably a restaurant.”. However, this might not be how investors see Chipotle Mexican Grill ( NYSE:CMG ). Chipotle’s stock is currently trading at a P/E ratio of around 54, while many

Latest News

Mogotes Announces Grant of Options

Newsfile

Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Mogotes Metals Inc. (TSXV: MOG) (FSE: OY4) (OTCQB: MOGMF) ("Mogotes" or the "Company") is pleased to announce that it has granted 350,000 stock options to purchase common shares exercisable at a p

The Grove Estate Expands Luxury Addiction Treatment in Rural Indiana

Newsfile

Rising overdose rates in Indiana drive demand for luxury residential rehab serving Indianapolis, Fort Wayne, and the MidwestPeru, Indiana--(Newsfile Corp. - April 10, 2026) - The Grove Estate is expanding access to addiction treatment services in rur

Sharp Therapeutics Updates on '901 for Gaucher and GBA1 Parkinson's and Platform Programs

Newsfile

Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") announces that following longer-term non-GLP testing the company has decided to advance

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

GlobeNewswire Inc.

WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the company received a complete respons

ImagineAR Provides Corporate Update

Newsfile

Vancouver, British Columbia--(Newsfile Corp. - April 10, 2026) - ImagineAR (CSE: IP) (the "Company" or "ImagineAR") today announced a strategic operational update in response to current market conditions.The Company has elected to temporarily suspend

Sharp Therapeutics Announces Closing of Fourth Tranche of Unsecured Convertible Note Offering

Newsfile

Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce that it has closed the fourth tranche (the "Fourth Tranche") of

Pelthos Therapeutics Announces CFO Transition

GlobeNewswire Inc.

Senior Vice President, Finance & Accounting John M. Gay named Chief Financial OfficerDURHAM, N.C., April 10, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative

Auric Minerals Corp. Announces Completion of Debt Settlement

Newsfile

Vancouver, British Columbia--(Newsfile Corp. - April 10, 2026) - Auric Minerals Corp. (CSE: AUMC) (FSE: QJ4) ("Auric" or the "Company") announces that, further to its news release of April 2, 2026, it has issued an aggregate of 1,028,570 common share

Trillion Energy Announces Asset Disposition and Royalty Agreement

Newsfile

Vancouver, British Columbia--(Newsfile Corp. - April 10, 2026) - Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) (FSE: Z620) ("Trillion" or the "Company") announces that, through a subsidiary it has entered into a sale agreement for all

Excellon Grants Stock Options and Share Units

Newsfile

Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Excellon Resources Inc. (TSXV: EXN) (OTC Pink: EXNRF) (FSE: E4X2) ("Excellon" or the "Company") announces that the Board of Directors has approved the grant of 1,705,000 stock options, 1,700,000 p